AKT1 and hepatocellular carcinoma: The SIRT1 agonist resveratrol acts as an antioxidant enzyme in alcohol-aflatoxin B1-induced HCC [94] and inhibits cancer cell proliferation through SIRT1-mediated modification of PI3K/AKT signaling [95].